Moore Capital Management LP Invests $3.22 Million in Danaher Corporation $DHR

Moore Capital Management LP acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 16,927 shares of the conglomerate’s stock, valued at approximately $3,224,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in DHR. EP Wealth Advisors LLC acquired a new stake in shares of Danaher during the second quarter worth $3,807,000. Northwestern Mutual Wealth Management Co. increased its holdings in Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Puzo Michael J acquired a new stake in shares of Danaher in the 2nd quarter valued at about $8,624,000. Madison Asset Management LLC acquired a new position in shares of Danaher during the second quarter worth about $85,451,000. Finally, First Nebraska Trust Co bought a new position in shares of Danaher during the second quarter worth about $14,106,000. Institutional investors own 79.05% of the company’s stock.

Get Danaher alerts:

Danaher Price Performance

Danaher stock opened at $213.90 on Tuesday. The stock’s 50 day moving average is $200.18 and its 200 day moving average is $192.31. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market cap of $150.37 billion, a P/E ratio of 37.99, a P/E/G ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.77 earnings per share. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on DHR. TD Cowen lowered their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. DZ Bank initiated coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Finally, Stifel Nicolaus reduced their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Check Out Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

• Five stocks we like better than Danaher
• Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
• Insiders Are Betting Big on These 3 Healthcare Stocks
• 3 Stocks for Investors Who Still Believe Cash Is King
• Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.